SAMRA FAJIC: Open Payments
NPI 1417589052 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,728 in 153 payments from 16 companies in 2025. Trend: 2023 $3,235 · 2024 $3,195 · 2025 $4,728
Food & beverage: $3,848Consulting: $880
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $1,199 |
| E.R. Squibb & Sons, L.L.C. | 1 | $880 |
| UCB, Inc. | 23 | $650 |
| AstraZeneca Pharmaceuticals LP | 18 | $388 |
| Amgen Inc. | 20 | $329 |
| Janssen Biotech, Inc. | 12 | $325 |
| Lilly USA, LLC | 11 | $244 |
| Novartis Pharmaceuticals Corporation | 6 | $154 |
| GlaxoSmithKline, LLC. | 7 | $135 |
| Mallinckrodt Hospital Products Inc. | 1 | $132 |
Products named: RINVOQ, Bimzelx, TREMFYA, SAPHNELO, SKYRIZI, TALTZ, BENLYSTA, ACTHAR.
Industry payments across MO — which companies pay providers there.
